In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET

被引：90

作者：

Kikuchi, Akio ^{[1
]}

Okamura, Nobuyuki ^{[2
]}

Hasegawa, Takafumi ^{[1
]}

Harada, Ryuichi ^{[2
]}

Watanuki, Shoichi ^{[4
]}

Funaki, Yoshihito ^{[5
]}

Hiraoka, Kotaro ^{[4
]}

Baba, Toru ^{[1
]}

Sugeno, Naoto ^{[1
]}

Oshima, Ryuji ^{[1
]}

Yoshida, Shun ^{[1
]}

Kobayashi, Junpei ^{[1
]}

Ezura, Michinori ^{[1
]}

Kobayashi, Michiko ^{[8
]}

Tano, Ohito ^{[9
]}

Mugikura, Shunji ^{[3
]}

Iwata, Ren ^{[5
]}

Ishiki, Aiko ^{[6
]}

Furukawa, Katsutoshi ^{[6
]}

Arai, Hiroyuki ^{[6
]}

Furumoto, Shozo ^{[5
]}

Tashiro, Manabu ^{[4
]}

Yanai, Kazuhiko ^{[2
]}

Kudo, Yukitsuka ^{[7
]}

Takeda, Atsushi ^{[10
]}

Aoki, Masashi ^{[1
]}

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi, Japan

[2] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan

[3] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, Sendai, Miyagi, Japan

[4] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Cyclotron Nucl Med, Sendai, Miyagi, Japan

[5] Tohoku Univ, Ctr Cyclotron & Radioisotope, Div Radiopharmaceut Chem, Sendai, Miyagi, Japan

[6] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Resp Med, Sendai, Miyagi, Japan

[7] Tohoku Univ, Inst Dev Aging & Canc, Div Neuroimaging, Sendai, Miyagi, Japan

[8] Tohoku Pharmaceut Univ Hosp, Dept Neurol, Sendai, Miyagi, Japan

[9] Sendai Med Ctr, Dept Neurol, Sendai, Miyagi, Japan

[10] Natl Hosp Org, Sendai Nishitaga Hosp, Dept Neurol, Sendai, Miyagi, Japan

来源：

NEUROLOGY | 2016年 / 87卷 / 22期

关键词：

PROGRESSIVE SUPRANUCLEAR PALSY; BETA-AMYLOID BURDEN; ALZHEIMERS-DISEASE; NEUROFIBRILLARY PATHOLOGY; DEGENERATION; DEMENTIA; TAUOPATHIES; DIAGNOSIS;

D O I：

10.1212/WNL.0000000000003375

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Objective: To determine whether F-18-THK5351 PET can be used to visualize tau deposits in brain lesions in live patients with corticobasal syndrome (CBS). Methods: We evaluated the in vitro binding of H-3-THK5351 in postmortem brain tissues from a patient with corticobasal degeneration (CBD). In clinical PET studies, F-18-THK5351 retention in 5 patients with CBS was compared to that in 8 age-matched normal controls and 8 patients with Alzheimer disease (AD). Results: H-3-THK5351 was able to bind to tau deposits in the postmortem brain with CBD. In clinical PET studies, the 5 patients with CBS showed significantly higher F-18-THK5351 retention in the frontal, parietal, and globus pallidus than the 8 age-matched normal controls and patients with AD. Higher F-18-THK5351 retention was observed contralaterally to the side associated with greater cortical dysfunction and parkinsonism. Conclusions: F-18-THK5351 PET demonstrated high tracer signal in sites susceptible to tau deposition in patients with CBS. F-18-THK5351 should be considered as a promising candidate radio-tracer for the in vivo imaging of tau deposits in CBS.

引用

页码：2309 / 2316

页数：8

共 50 条

[1] 18F-THK5351 PET in corticobasal syndrome
Kikuchi, A.
Okamura, N.
Hasegawa, T.
Ezura, M.
Baba, T.
Sugeno, N.
Yoshida, S.
Kobayashi, J.
Arai, H.
Furumoto, S.
Tashiro, M.
Yanai, K.
Kudo, Y.
Takeda, A.
Aoki, M.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 802 - 802
[2] High sensitivity of asymmetric 18F-THK5351 PET abnormality in patients with corticobasal syndrome
Kurihara, Masanori
Ishibashi, Kenji
Matsubara, Tomoyasu
Hatano, Keiko
Ihara, Ryoko
Higashihara, Mana
Kameyama, Masashi
Tokumaru, Aya Midori
Takeda, Katsuhiko
Nishina, Yasushi
Kanemaru, Kazutomi
Ishii, Kenji
Iwata, Atsushi
SCIENTIFIC REPORTS, 2023, 13 (01)
[3] High sensitivity of asymmetric 18F-THK5351 PET abnormality in patients with corticobasal syndrome
Masanori Kurihara
Kenji Ishibashi
Tomoyasu Matsubara
Keiko Hatano
Ryoko Ihara
Mana Higashihara
Masashi Kameyama
Aya Midori Tokumaru
Katsuhiko Takeda
Yasushi Nishina
Kazutomi Kanemaru
Kenji Ishii
Atsushi Iwata
Scientific Reports, 13
[4] Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
Ryuichi Harada
Shozo Furumoto
Tetsuro Tago
Furukawa Katsutoshi
Aiko Ishiki
Naoki Tomita
Ren Iwata
Manabu Tashiro
Hiroyuki Arai
Kazuhiko Yanai
Yukitsuka Kudo
Nobuyuki Okamura
European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2211 - 2218
[5] Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
Harada, Ryuichi
Furumoto, Shozo
Tago, Tetsuro
Katsutoshi, Furukawa
Ishiki, Aiko
Tomita, Naoki
Iwata, Ren
Tashiro, Manabu
Arai, Hiroyuki
Yanai, Kazuhiko
Kudo, Yukitsuka
Okamura, Nobuyuki
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2211 - 2218
[6] Longitudinal changes in 18F-THK5351 positron emission tomography in corticobasal syndrome
Ezura, M.
Kikuchi, A.
Ishiki, A.
Okamura, N.
Hasegawa, T.
Harada, R.
Watanuki, S.
Funaki, Y.
Hiraoka, K.
Baba, T.
Sugeno, N.
Oshima, R.
Yoshida, S.
Kobayashi, J.
Kobayashi, M.
Tano, O.
Nakashima, I.
Mugikura, S.
Iwata, R.
Taki, Y.
Furukawa, K.
Arai, H.
Furumoto, S.
Tashiro, M.
Yanai, K.
Kudo, Y.
Takeda, A.
Aoki, M.
EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (09) : 1205 - 1211
[7] Erratum to: Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
Ryuichi Harada
Shozo Furumoto
Tetsuro Tago
Katsutoshi Furukawa
Aiko Ishiki
Naoki Tomita
Ren Iwata
Manabu Tashiro
Hiroyuki Arai
Kazuhiko Yanai
Yukitsuka Kudo
Nobuyuki Okamura
European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 177 - 177
[8] Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
Harada, Ryuichi
Ishiki, Aiko
Kai, Hideaki
Sato, Naomi
Furukawa, Katsutoshi
Furumoto, Shozo
Tago, Tetsuro
Tomita, Naoki
Watanuki, Shoichi
Hiraoka, Kotaro
Ishikawa, Yoichi
Funaki, Yoshihito
Nakamura, Tadaho
Yoshikawa, Takeo
Iwata, Ren
Tashiro, Manabu
Sasano, Hironobu
Kitamoto, Tetsuyuki
Yanai, Kazuhiko
Arai, Hiroyuki
Kudo, Yukitsuka
Okamura, Nobuyuki
JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 671 - 674
[9] 18F-THK5351 PET in Patients with Clinically Diagnosed PSP
Rominger, A.
Brendel, M.
Schonecker, S.
Hoeglinger, G.
Lindner, S.
Danek, A.
Levin, J.
Bartenstein, P.
Okamura, N.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S132 - S132
[10] Prediction of prognosis for mild cognitive impairment by 18F-THK5351 PET
Ishiki, A.
Ueda, J.
Tomita, N.
Numasaki, M.
Okinaga, S.
Arai, H.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S92 - S92

← 1 2 3 4 5 →